22/05/2020 - 11:16

Invex raises $26m for clinical trials

22/05/2020 - 11:16

Bookmark

Save articles for future reference.

Invex Therapeutics has received a $5 million investment from Andrew Forrest’s Tattarang as part of a share placement, with the proceeds to go towards the company’s research into neurological diseases.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options